Cargando…
Prognostic Significance of BIRC5/Survivin in Breast Cancer: Results from Three Independent Cohorts
SIMPLE SUMMARY: Survivin, coded by the BIRC5 gene, is the cell death preventing protein, which is important for cell division in normal and cancer cells. It is intensively studied as a cancer biomarker and target for antitumor therapy. In this study we asked if we could get clinically helpful inform...
Autores principales: | Oparina, Nina, Erlandsson, Malin C., Fäldt Beding, Anna, Parris, Toshima, Helou, Khalil, Karlsson, Per, Einbeigi, Zakaria, Bokarewa, Maria I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125570/ https://www.ncbi.nlm.nih.gov/pubmed/34064473 http://dx.doi.org/10.3390/cancers13092209 |
Ejemplares similares
-
Pan-cancer analysis identifies BIRC5 as a prognostic biomarker
por: Fäldt Beding, Anna, et al.
Publicado: (2022) -
Survivin promotes a glycolytic switch in CD4(+) T cells by suppressing the transcription of PFKFB3 in rheumatoid arthritis
por: Erlandsson, Malin C., et al.
Publicado: (2022) -
Genetic alterations associated with multiple primary malignancies
por: Nyqvist, Jenny, et al.
Publicado: (2021) -
Previously diagnosed multiple primary malignancies in patients with breast carcinoma in Western Sweden between 2007 and 2018
por: Nyqvist, Jenny, et al.
Publicado: (2020) -
The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004–2014)
por: De Lara, Shahin, et al.
Publicado: (2019)